1. Apatinib-Induced Hand–Foot Skin Reaction in Chinese Patients With Liver Cancer
   Hui Xia et al, 2021, Frontiers in Oncology CrossRef
2. Apatinib Inhibits Bladder Cancer through Suppression of the VEGFR2- PI3K-AKT Signaling Pathway as Revealed by Network Pharmacology and in vitro Experimental Verification
   Weiwei Wang et al, 2023, Combinatorial Chemistry & High Throughput Screening CrossRef
3. Apatinib as an alternative therapy for advanced hepatocellular carcinoma
   Xi-Hao Zhang et al, 2020, World Journal of Hepatology CrossRef
4. Efficacy and safety of apatinib versus sorafenib/placebo in first-line treatment for intermediate and advanced primary liver cancer: A systematic review and meta-analysis
   Dan Peng et al, 2023, Frontiers in Pharmacology CrossRef
5. Apatinib, a Novel Tyrosine Kinase Inhibitor, Promotes ROS-Dependent Apoptosis and Autophagy via the Nrf2/HO-1 Pathway in Ovarian Cancer Cells
   Xiaodan Sun et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
6. Shape Designed Implanted Drug Delivery System for In Situ Hepatocellular Carcinoma Therapy
   Chaochao Zhao et al, 2022, ACS Nano CrossRef
7. Stimulator of interferon response cGAMP interactor overcomes ERBB2-mediated apatinib resistance in head and neck squamous cell carcinoma
   Guo Ye et al, 2021, Aging CrossRef